Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL

BACKGROUND: Advanced prostate cancer is a phenotypically diverse disease that evolves through multiple clinical courses. PSA level is the most widely used parameter for disease monitoring, but it has well-recognized limitations. Unlike in clinical trials, in practice, clinicians may rely on PSA moni...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Prostate Cancer Prostatic Dis
Главные авторы: Bryce, A H, Alumkal, J J, Armstrong, A, Higano, C S, Iversen, P, Sternberg, C N, Rathkopf, D, Loriot, Y, de Bono, J, Tombal, B, Abhyankar, S, Lin, P, Krivoshik, A, Phung, D, Beer, T M
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2017
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5435962/
https://ncbi.nlm.nih.gov/pubmed/28117385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2016.71
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы